His primary areas of investigation include Alzheimer's disease, Internal medicine, Dementia, Endocrinology and Apolipoprotein E. His Alzheimer's disease research incorporates elements of Biomarker and Cognitive decline. Internal medicine is closely attributed to Oncology in his research.
His Dementia study integrates concerns from other disciplines, such as Gerontology, Diabetes mellitus, Clinical psychology, Neuroscience and Amyloid. His Endocrinology research focuses on subjects like Gene isoform, which are linked to High cholesterol, Guinea pig, Cavia and Regulation of gene expression. Ralph N. Martins has researched Apolipoprotein E in several fields, including Apolipoprotein B, Immunology, Allele, Lipoprotein and Degenerative disease.
Ralph N. Martins mainly focuses on Internal medicine, Disease, Alzheimer's disease, Endocrinology and Dementia. His Oncology research extends to the thematically linked field of Internal medicine. His work deals with themes such as Clinical trial, Bioinformatics, Neuroscience and Ageing, which intersect with Disease.
His Alzheimer's disease research includes elements of Biomarker, Prospective cohort study and Immunology, Pathogenesis. The study incorporates disciplines such as Psychiatry, Neuroimaging and Neuropsychology in addition to Dementia. The various areas that Ralph N. Martins examines in his Cognitive decline study include Cognition and Gerontology.
His primary scientific interests are in Disease, Internal medicine, Cognition, Dementia and Endocrinology. Ralph N. Martins combines subjects such as Cerebrospinal fluid, Neuroscience, Gerontology and Bioinformatics with his study of Disease. In his study, Neurology is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
Ralph N. Martins has included themes like Neuropathology, Neuropsychology and Confidence interval in his Dementia study. His research investigates the connection between Endocrinology and topics such as Neurodegeneration that intersect with problems in Hippocampus. His biological study focuses on Clinical Dementia Rating.
Disease, Alzheimer's disease, Internal medicine, Cognition and Cognitive decline are his primary areas of study. His work in Dementia and Apolipoprotein E are all subfields of Disease research. His Alzheimer's disease study combines topics in areas such as Biomarker, Cerebrospinal fluid, Pathogenesis and Stroke.
His research integrates issues of Strength training, Endocrinology and Oncology in his study of Internal medicine. Ralph N. Martins combines subjects such as Cognitive health, Gerontology, Audiology and Intervention studies with his study of Cognition. His research in Cognitive decline intersects with topics in Memory disorder, Homocysteine, Clinical trial, Randomized controlled trial and Ageing.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease
Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan.
The New England Journal of Medicine (2012)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown.
Lancet Neurology (2013)
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
C L Masters;G Multhaup;G Simms;J Pottgiesser.
The EMBO Journal (1985)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat.
Neurobiology of Aging (2010)
Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease
Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis.
Annals of Neurology (2011)
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Baden Rumble;Robert Retallack;Caroline Hilbich;Gail Simms.
The New England Journal of Medicine (1989)
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio.
International Psychogeriatrics (2009)
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato.
A4 amyloid protein deposition and the diagnosis of Alzheimer's disease Prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques
L. Davies;B. Wolska;B. Wolska;C. Hilbich;G. Multhaup.
CLINICAL AND BIOMARKER CHANGES IN DOMINANTLY INHERITED ALZHEIMER'S DISEASE
PR Schofield;RJ Bateman;C Xiong;Tls Benzinger.
Clinical and Experimental Pharmacology and Physiology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: